Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience.
about
Current treatment options for myeloma.The treatment of the elderly multiple myeloma patients.Melphalan: old and new uses of a still master drug for multiple myeloma.Novel therapies delay the progression of smoldering multiple myeloma: Case report and discussion.Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy.
P2860
Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience.
@ast
Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience.
@en
Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience.
@nl
type
label
Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience.
@ast
Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience.
@en
Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience.
@nl
prefLabel
Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience.
@ast
Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience.
@en
Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience.
@nl
P2093
P1476
Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience.
@en
P2093
Alexanian R
Jacobson J
P304
P356
10.1016/S0037-1963(01)90011-3
P577
2001-07-01T00:00:00Z